Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with RUNX1-RUNX1T1 or CBFB-MYH11 Fusions | Turk J Haematol | 2022 | 35445594 | PubTator, text mining | PubMed |
| MicroRNA serum profiles and chronic graft-versus-host disease. | Blood Adv | 2022 | 35443023 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Mapping human haematopoietic stem cells from haemogenic endothelium to birth. | Nature | 2022 | 35418685 | PubTator, text mining | PubMed |
| Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. | Bone Marrow Transplant | 2022 | 35413985 | PubTator, text mining | PubMed |
| Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States. | Leuk Lymphoma | 2022 | 35412943 | PubTator, text mining | PubMed |
| CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma. | Cell Death Dis | 2022 | 35411000 | PubTator, text mining | PubMed |
| FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms. | Int J Mol Sci | 2022 | 35409166 | PubTator, text mining | PubMed |
| Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging. | Int J Mol Sci | 2022 | 35409034 | PubTator, text mining | PubMed |
| Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases. | Cells | 2022 | 35406663 | PubTator, text mining | PubMed |
| RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity? | Cancers (Basel) | 2022 | 35406615 | PubTator, text mining | PubMed |
| The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia. | Blood Sci | 2022 | 35399543 | PubTator, text mining | PubMed |
| Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells. | Blood Sci | 2022 | 35399539 | PubTator, text mining | PubMed |
| TET2 regulates immune tolerance in chronically activated mast cells. | JCI Insight | 2022 | 35393954 | PubTator, text mining | PubMed |
| Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3". | Blood Cancer J | 2022 | 35393398 | PubTator, text mining | PubMed |
| [Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia: a single-institution experience]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35381674 | PubTator, text mining | PubMed |
| MiR-223 as a Regulator and Therapeutic Target in Liver Diseases. | Front Immunol | 2022 | 35371024 | PubTator, text mining | PubMed |
| Single base substitution and insertion/deletion mutational signatures in adult core binding factor acute myeloid leukemia. | Leukemia | 2022 | 35365774 | PubTator, text mining | PubMed |
| Roles of RNA Modifications in Diverse Cellular Functions. | Front Cell Dev Biol | 2022 | 35350378 | PubTator, text mining | PubMed |
| Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification. | Nat Commun | 2022 | 35347147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=39